FINWIRES · TerminalLIVE
FINWIRES

Renewed Tensions in Middle East Dampen US Equity Futures Pre-Bell

-- US equity futures were lower pre-bell on Monday as tensions escalated in the Middle East once again after the US seized an Iranian cargo ship that tried to run the US blockade of Iran's ports, and Iran refused to restart peace negotiations with the US in Pakistan.

Dow Jones Industrial Average futures were 0.6% lower, S&P 500 futures were down 0.6%, and Nasdaq futures were 0.5% lower.

The US had said it wanted to resume negotiations before the two-week ceasefire with Iran ends on Tuesday, but Iran's foreign ministry said it would not join new talks due the ongoing blockade and "excessive demands" of the US.

Over the weekend, Iran lifted and then reimposed its own blockade on vessels passing through the Strait of Hormuz.

Some of the companies expected to report quarterly earnings this week are GE Aerospace (GE) and UnitedHealth Group (UNH) pre-bell on Tuesday, Tesla (TSLA) and IBM (IBM) after-market on Wednesday, Intel (INTC) after-market on Thursday, and Procter & Gamble (PG) pre-bell on Friday.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 4.8% at $94.73 per barrel and US West Texas Intermediate crude 5.7% higher at $87.29 per barrel.

The economic calendar is vacant.

Related Articles

Research

Research Alert: CFRA Maintains Buy Rating On Shares Of Quest Diagnostics

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month price target at $235. This is based on a forward P/E of 21.9x our 2026 EPS estimate, a premium to DGX's three-year forward average of 16.8x due to our view of strengthening sales and earnings growth, backed by higher health care utilization trends and some regulatory relief due to postponement of lab reimbursement cuts until at least 2027. We think lab testing providers remain a relatively well-positioned area within health care given lower policy risks, supportive testing demand, and attractive earnings growth potential. On a compounded annual basis from 2025-2028, we expect near 8% EPS growth, raising our 2026 EPS to $10.73 from $10.60 and 2027 EPS to $11.50 from $11.42. We also anticipate additional smaller M&A opportunities, along with healthy dividend increases (recent 7.5% boost; shares yield 1.7%) as cash flow generation remains supportive over the near term.

$DGX
Research

Research Alert: Pega: Q1 Results Miss, But Strength In Pega Cloud Offsets

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEGA reported total revenue of $430M, missing consensus by $37.2M and declining 10% Y/Y, while non-GAAP EPS of $0.46 missed by $0.23 and fell 39% Y/Y. However, Pega Cloud revenue surged 36% Y/Y to $205M, now representing 47.7% of total revenue and validating the cloud transition thesis. Pega Cloud annual contract value (ACV) acceleration remains the standout metric, growing 29% Y/Y to $906.7M and accelerating from 23% growth in Q1, demonstrating continued strong demand for the company's AI workflow automation platform. Total ACV grew 12% Y/Y to $1.62B, with backlog increasing 16% Y/Y to $2.01B providing revenue visibility. We believe the robust cash flow generation of $206.5M in free cash flow and a solid balance sheet with $474M in cash provides financial flexibility for continued AI investment. Despite near-term profitability pressure, we expect the sustained Pega Cloud momentum and strong ACV growth to support the business transformation.

$PEGA
Asia

Air New Zealand CFO to Resign

Air New Zealand (ASX:AIZ, NZE:AIR) said that Chief Financial Officer Richard Thomson has resigned, effective Aug. 28, according to a Wednesday filing with the New Zealand bourse.The airline has started the process of searching for a new CFO, the filing added.

$ASX:AIZ$NZE:AIR